Salvatori, Roberto http://orcid.org/0000-0001-6495-2244
Maffei, Pietro
Webb, Susan M.
Brue, Thierry
Loftus, Jane
Valluri, Srinivas Rao
Gomez, Roy
Wajnrajch, Michael P.
Fleseriu, Maria
Funding for this research was provided by:
Pfizer (NA)
Article History
Accepted: 3 January 2022
First Online: 12 January 2022
Declarations
:
: RS is an editor for Pituitary; MF and TB are on the Editorial Board of Pituitary. RS is a principal investigator with research support to Johns Hopkins University for clinical research studies with Crinetics, Novartis, and Chiasma and occasional scientific consultant for Ipsen and Recordati. PM has received honoraria as consultant/speaker, and is a principal investigator for research grants from CamurusAB, Ipsen, Novartis, Pfizer. SMW has received honoraria as consultant/speaker or is a principal investigator for research grants from: Pfizer, Novartis, Ipsen, Recordati, HRA, Crinetics and Corcept. TB has received honoraria as consultant/speaker, or is a principal investigator for research grants from: Pfizer, Novartis Pharma, Ipsen Pharma, Recordati, Merck-Serono, Sandoz, Novo-Nordisk, Advanz Pharma, and Corcept. JL, MPW, SRV, and RG are employees of Pfizer and are stockholders of Pfizer. MF is a principal investigator with research support at Oregon Health & Science University for clinical research studies with Crinetics, Novartis, Recordati, Chiasma, Ionis and occasional scientific consultant for Crinetics, Pfizer, Ipsen, Recordati, and Chiasma.